Home Commercial Roche Looking to Shutter its Vacaville Plant Valued at $700MM
CommercialFinanceINDUSTRY newsLife Science

Roche Looking to Shutter its Vacaville Plant Valued at $700MM

Share
Share

By The Registry Staff Roche Holding AG, the renowned Swiss drugmaker, has announced its intention to divest its drug manufacturing facility in Vacaville, California, located at 1000 New Horizons Way. The company aims to sell the plant, which currently employs around 800 individuals, or alternatively, shut it down by 2029, as revealed in internal communications […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

Partner Content

2026 Northern California CRE Rising Stars

NorCal rising stars 2026

Partner Content


Recent Posts

Related Articles

OpenAI’s Jony Ive-Led Hardware Team Leases 115,000 SQFT at 475 Sansome in San Francisco’s Financial District

OpenAI's hardware group, built around Jony Ive's former startup io, has closed...

Buzz Oates Sells Fully Leased 150,000 SQFT Stockton Warehouse for $21.25MM

A private investor pays about $142 per square foot for a renovated,...

Macerich Acquires 1.1MM SQFT Oakridge Mall in San Jose for $250MM in All-Equity Deal

Macerich has bought Oakridge Mall, the single-level enclosed shopping center at the...